Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
25 Results for "
P52
" in MedChemExpress (MCE) Product Catalog:
Products (25)
25 Results for "P52" in MCE Product Catalog:
5
5 Cited Publications
Cat. No.: HY-P3229
CAS No.: 1071173-56-2
3
1
1 Cited Publications
JS6 is a Bcl3 inhibitor. JS6 attenuates the binding of Bcl3 to NF-κB1 (p50), disrupts the binding of Bcl3 to NF-κB family proteins p50 and p52, and inhibits the NF-κB signaling pathway. JS6 is applicable to breast cancer-related research .
Target:
Research Areas:
LTβR-IN-1 (Compound 919278) is a potent, selective lymphotoxin β receptor (LTβR) inhibitor. LTβR-IN-1 also selectively inhibits the nuclear translocation of p52 depended on TNF12A, instead of the nuclear translocation of p65 mediated by TNF-α receptor. LTβR-IN-1 regulates the NF-kB signaling pathway IN a ligand-independent manner .
Cat. No.: HY-RS05901
Target:
Research Areas:
GTF2H4 Human Pre-designed siRNA Set A contains three designed siRNAs for GTF2H4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS09258
Target:
Research Areas:
Nfkb2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nfkb2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS10771
Target:
Research Areas:
PMPCB Human Pre-designed siRNA Set A contains three designed siRNAs for PMPCB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS11289
Target:
Research Areas:
PSIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for PSIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS04964
Target:
Research Areas:
FKBP4 Human Pre-designed siRNA Set A contains three designed siRNAs for FKBP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS09257
Target:
Research Areas:
NFKB2 Human Pre-designed siRNA Set A contains three designed siRNAs for NFKB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P79208
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PSIP1; PC4 And SFRS1 Interacting Protein 1; Prev. PSIP2; CLL-Associated Antigen KW-7; Lens Epithelium-Derived Growth Factor; PC4 And SFRS1 Interacting Protein 2; LEDGF; Transcriptional Coactivator P52/P75; DFS70; Transcriptional Coactivator P75/P52; PC4 A
Species:
Human
Source:
E. coli
Cat. No.: HY-L014
1,770 compounds
Nuclear factor-κB (NF-κB)/Rel proteins include NF-κB2 p52/p100, NF-κB1 p50/p105, c-Rel, RelA/p65, and RelB. These proteins function as dimeric transcription factors that regulate the expression of genes and influence a broad range of biological processes including innate and adaptive immunity, inflammation, stress responses, B-cell development, and lymphoid organogenesis. NF-κB plays a key role in regulating the immune response to infection. In addition, activation of the NF-κB pathway is involved in the pathogenesis of chronic inflammatory diseases, such as asthma, rheumatoid arthritis, and inflammatory bowel disease. Incorrect regulation of NF-κB has been linked to cancer, inflammatory and autoimmune diseases, septic shock, viral infection, and improper immune development.
MCE owns a unique collection of 1,770 small molecule compounds that can be used in the research of NF-κB signaling pathway or high throughput screening (HTS) related drug discovery.
Cat. No.: HY-P702972
Purity: ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: NFKB2; H2TF1; Nuclear Factor Kappa B Subunit 2; LYT10; Nuclear Factor NF-Kappa-B P100 Subunit; P105; DNA-Binding Factor KBF2; Nuclear Factor Of Kappa Light Chain Gene Enhancer In B Cells 2; P49/P100; Nuclear Factor NF-Kappa-B P52 Subunit; LYT-10; Nuclear
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-179701
Target:
Research Areas:
NIK-IN-3 is a potent and orally active NF-κB-inducing kinase (NIK) inhibitor with an IC50 of 5.2 nM. NIK-IN-3 suppresses non-canonical NF-κB pathway activation and inhibits the secretion of pro-inflammatory cytokines, such as TNF-α, IL-6, IL-1β and chemokine CXCL12. NIK-IN-3 shows significant anti-inflammatory effects in LPS (HY-D1056)-induced sepsis mice model and DSS (HY-116282)-induced colitis model. NIK-IN-3 can be used for the research of inflammation, such as colitis .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
